Zhang, M.,* Kim, J. Effect of size and molecular pattern on the internalization of water soluble β-(1-3)-(1-4)-glucans by primary murine macrophages. The International Journal of Biochemistry & Cell Biology. 2012, 44:914. PubMed PMID: 22679629.

Visioni, A., Zhang, M.*, Graor, H., Kim, J.* Expansion of Melanoma-Specific T cells from Lymph Nodes of Stage III Patients: Implications for Adoptive Immunotherapy of Cancer, Surgery. 2012, 152:557. PMID: 22925133

Lu, Y., Gao, Y., Pierce, R., Dai, L., Kim, J., Zhang, M.* Development of Y-shaped peptide for constructing nanoparticle systems targeting tumor-associated macrophages in vitro and in vivo. Material Research Express. 2014, 1: 025007 Doi: 10.1088/2053-1591/1/2/025007

Zhang, M.*, Naik, R. and Dai, L. Carbon Nanomaterials for Biomedical Applications. in Springer Series in Biomaterials Science and Engineering, Springer: NY, 2013.

Zhang, M.*, He, P., and Dai, L. Biomedical Applications of Nanostructures: Carbon Nanotube Biosensors. in Carbon Nanomaterials, 2nd ed. (Eds. Yury Gogotsi and Volker Presser), CRC Presss, Taylor & Francis:Boca Raton, FL, 2013.

Zhang, M.*, Dai, L. Carbon nanomaterials as metal-free catalysts for oxygen reduction in next generation fuel cells. Nano Energy. 2012 4:514-517. Doi: 10.1016/j.nanoen.2012.02.008

Zhang, M.,* Graor, H., Visioni, A., Madelleine, S., Yan, L., Caja, K., Kim, J.* T cells derived from Human Melanoma Draining Lymph Nodes mediate melanoma specific antitumor responses in vitro and in vivo in human melanoma xenograft model. Journal of Immunotherapy. 2015, 38: 229-238. PMID: 26049546

Zhang M.,* Graor H, Yan L, KIM J.* Identification of melanoma-reactive CD4+ T cell subsets from human melanoma draining lymph nodes. J Immunotherapy 2016, 39: 15 – 26 . PMCID: PMC4672391

Zhang, M.,* Yan, L., Kim J. * Modulating mammary tumor growth, metastasis and immunosuppression by siRNA-induced MIF reduction in tumor microenvironment. Cancer Gene Therapy. 2015, 1-12. PMID: 26403072 Wilkerson, A., Kim, J., Zhang, M*. Nanoparticle systems modulating myeloid-derived suppressor cells for cancer immunotherapy. Current Topics in Medicinal Chemistry. 2017, 17, 1-15. PMID: 27875974

Zhang, M*., Kim J. and Huang, A. Modulating tumor microenvironment for cancer immunotherapy: beta-glucan and beta-glucan-based nanoparticles. Frontiers in Immunology. 2018, 9:341

Zhang, M*., Chun, L., Kim, J., Huang, A. Systemic administration of beta-glucan of 200 kDa modulates melanoma microenvironment and suppress metastatic cancer. OncoImmunology, 2018, 7(2): e1387347 PMID: 29308312

Patents

Method for generating tumor-specific T cells. Filed on March 11, 2014. No. 14/205,069 BG34-200 Immunotherapeutic for solid tumor cancers. Filed on August 11, 2018. No. U.S. Patent Application No. 16/059,511